Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease. PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date.
Prenetics Acquires Oxsed, Oxford University Spin-out to Scale Rapid COVID-19 Test Globally. Rapid Airport Testing has begun in Heathrow with Trials in Hong Kong International Airport.
Oct 30, 2020 |
OncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 Clinical Trial of its CORVax12 Vaccine Candidate for COVID-19
Oct 29, 2020 |
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
Oct 29, 2020 |
Kintor Pharmaceutical’s COVID-19 Clinical Trials for Proxalutamide to expand Patient Enrolment
Oct 29, 2020 |
Data for Lilly’s bamlanivimab (LY-CoV555) in COVID-19 outpatients published in New England Journal of Medicine
Oct 28, 2020 |
Regeneron’s COVID-19 Outpatient Trial Prospectively Demonstrates that REGN-COV2 Antibody Cocktail Significantly Reduced Virus Levels and Need for Further Medical Attention
Oct 28, 2020 |
COVID-19 Immune Response Study Could Lead to More Effective Treatments
Oct 28, 2020 |
JadiCell™ Stem Cells Licensed by Therapeutic Solutions International for Brain Injury Significantly Increased Survival of COVID-19 Patients in Double Blind FDA Clinical Trial
Oct 28, 2020 |
Daewoong Pharmaceutical’s COVID-19 Treatment Candidate Also Highly Effective against Influenza Virus
Oct 28, 2020 |
Qualigen Therapeutics Receives Positive Pre-IND Response from FDA for the Clinical Development of AS1411 as a Treatment for COVID-19
Oct 28, 2020 |
Ampio Begins Phase 1 Clinical Trial of Inhaled Ampion For COVID-19 Patients With Respiratory Distress
Oct 28, 2020 |
Companies could face difficulties registering cleaners and disinfectants with claims of “long-lasting” effectiveness against COVID-19, says TSG Consulting
Oct 27, 2020 |
Daewoong Pharmaceutical’s Long-Acting Niclosamide Shows High Promise Against Upcoming COVID-19 ‘Twindemic’
Oct 27, 2020 |
Quest Diagnostics and Catapult Health Provide Virtual Preventive Care Services for Employers During COVID-19 Pandemic and Beyond
Oct 27, 2020 |
Ampio Presents at Roth Capital Partners 2020 MedTech Innovation Forum Focusing on COVID-19 Clinical Trial Activities
Oct 26, 2020 |
Clinical Study Begins for the First Oral Systemic Nitric Oxide Based Therapeutic for African Americans with COVID-19
Oct 26, 2020 |
Truvian Sciences Announces Plans to Make Rapid Antibody Testing More Accessible with Easy Check COVID-19 IgM/IgG™ POC Antibody Test
Oct 26, 2020 |
Helix Receives Expanded Emergency Use Authorization for On-site Unsupervised Self-Collection and Asymptomatic Screening with the Helix® COVID-19 Test
Oct 26, 2020 |
SQI Diagnostics Updates Clinical Progress on Novel COVID-19 Tests Under Development for U.S. FDA Regulatory Submission
Oct 26, 2020 |
Biophytis Enrolls First Patient in Brazil in COVA, a Multinational Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patients with COVID-19 Related Respiratory Failure
Oct 26, 2020 |
Entos Pharmaceuticals Awarded funding to Conduct Phase I Clinical Trial of COVID-19 DNA Vaccine
Oct 23, 2020 |
FDA Approves First Treatment for COVID-19
Oct 22, 2020 |
Arizona Based Biotech Company Finds Preliminary Success Developing an Intranasal COVID-19 Vaccine Alternative
Oct 22, 2020 |
TrippBio Announces the Completion of Enrollment in a Proof of Concept Clinical Trial Evaluating the Efficacy of TD213 in Treating Patients with Confirmed COVID-19 Infections
Oct 22, 2020 |
Fresenius Medical Care North America Presents New Insights Related to COVID-19 and Dialysis Innovations at Kidney Week 2020
Oct 22, 2020 |
Alight and THINKMD Rapidly Adapt Established Medical Infrastructure in Fight Against COVID-19
Oct 22, 2020 |
Kedrion’s Partner, Kamada Ltd, Signs a Supply Agreement with the Israeli Health Authorities for the Investigational Anti-COVID-19 Plasma-Derived Therapy
Oct 22, 2020 |
Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine
Oct 22, 2020 |
COVID-19 Respiratory Monitoring with MediPines AGM100® in Long-Term Care Facilities
Oct 22, 2020 |
Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies for the Treatment of COVID-19
Oct 21, 2020 |
Facilitating the ‘Vaccine Era’ of COVID-19 Response: ThermoGenesis to Receive U.S. Patent for Breakthrough Serological Test Reader Technology
Oct 20, 2020 |
CSL’s Broad Response to COVID-19 and Advancements across the Company’s Strategic Scientific Platforms are the Focus of Annual R&D Day
Oct 20, 2020 |
OPKO Health’s BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test
Oct 20, 2020 |
IncellDx to Study Maraviroc, a CCR5 antagonist, in a COVID-19 Phase 2 Clinical Trial
Oct 20, 2020 |
EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy
Oct 20, 2020 |
NHS Hospitals trial ground-breaking new decontamination technology to reduce COVID-19 transmission indoors
Oct 20, 2020 |
Open Orphan/hVIVO Signs Contract with UK Government for the Development of a COVID-19 Human Challenge Study Model
Oct 20, 2020 |
Aridis Pharmaceuticals Reports Positive Preclinical Efficacy Data of a Highly Effective Inhaled Treatment Supporting a Proposed Self-Administered Therapy for COVID-19 Patients
Oct 19, 2020 |
Thermo Fisher Scientific Increases Availability of COVID-19 Testing with Sample Collection Kit from Everlywell
Oct 19, 2020 |
DxTerity Announces a New At-Home COVID-19 Testing Solution
Oct 19, 2020 |
Aetion Statement on UCSF-Led Study to Inform Drug Development for COVID-19, Future Pandemics
Oct 15, 2020 |
Genalyte Obtains FDA Emergency Use Authorization for Rapid COVID-19 Antibody Test
Oct 15, 2020 |
Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children
Oct 15, 2020 |
Eiger BioPharmaceuticals Announces Positive Results of Investigator Sponsored Randomized Controlled Trial at University of Toronto with Peginterferon Lambda in Outpatients with Mild to Moderate COVID-19
Oct 15, 2020 | Clinical Trial
No Aborted Fetal Material in AVM Biotechnology’s COVID-19 Treatment Drug
Oct 14, 2020 |
New blood test predicts which Covid-19 patients will develop severe infection
Oct 14, 2020 |
Novellus Therapeutics Exclusively Licenses Induced Mesenchymal Stem Cells (iMSCs) to NoveCite for COVID-19 Related Acute Respiratory Distress Syndrome (ARDS) and Other Acute Respiratory Conditions
Oct 13, 2020 |
Medigen’s COVID-19 Vaccine Combined with Dynavax’s CpG 1018 Adjuvant Receives Taiwan Government Subsidy with First Participant Dosed in Early October
Oct 13, 2020 |
NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100™ (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19
Oct 13, 2020 |
University of Milan Study Finds Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Test has 100% Specificity
Oct 12, 2020 |
Abbott Receives FDA Emergency Use Authorization for its COVID-19 IgM Antibody Blood Test
Oct 12, 2020 |
Review Article, Authored by ZyVersa Therapeutics’ Esteemed Scientific Advisors, Demonstrates the Role of Inflammasomes in the Exacerbated Immune Response Associated with COVID-19 Infection (Just Published in Frontiers in Immunology)
Oct 12, 2020 |
The Covid-19 pandemic is expected to further affect RhoVac’s clinical phase IIb study
Oct 12, 2020 | Clinical Trial
Rigel Announces First Patients Enrolled in NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova
Oct 9, 2020 | Collaboration
Grifols’ anti-SARS-CoV-2 hyperimmune globulin begins clinical trial in patients with COVID-19
Oct 9, 2020 | Clinical Trial
Exogenesis Surgical Mask Reaches Primary Endpoints in COVID-19 Deactivation Challenge Trials
Oct 9, 2020 | Clinical Trial
First Patient Enrolled in NIH Phase 3 Trial to Evaluate Potential COVID-19 Hyperimmune Medicine
Oct 8, 2020 | Clinical Trial
Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen
Oct 8, 2020 |
Johnson & Johnson Receives European Commission Approval of Agreement to Supply 200 Million Doses of Janssen’s COVID-19 Vaccine Candidate
Oct 8, 2020 | Collaboration
Prevea Health Selects Syntellis as Financial Planning Partner to Navigate COVID-19 Market Volatility
Oct 7, 2020 |
Abbott Reports Results of ID NOW™ COVID-19 Interim Clinical Study from 1,003 People to Provide the Facts on Clinical Performance and to Support Public Health
Oct 7, 2020 | Clinical Trial
Centaur Biopharmaceutical Signs Expansion Agreement with Vaxart of Manufacturing for COVID-19 and Other Vaccine Candidates
Oct 7, 2020 | Collaboration
Promising Research Showing New Way To Treat And Stop The Spread Of COVID-19 Using Gene Silencing And Reactivation Of “Innate” Immune System
Oct 6, 2020 |
Karyopharm Presents Results of Selinexor at the International Society for Influenza and Other Respiratory Virus Diseases Antiviral Group Virtual Conference on Therapeutics for COVID-19
Oct 6, 2020 | Clinical Trial
CLEAR Collaborates with Quest Diagnostics to Integrate COVID-19 Test Results with “Health Pass” for Safer Environments
Oct 5, 2020 | Collaborates
Hematogenix Unites With 19 Organizations from the Healthcare Community to Form COVID-19 Testing Industry Consortium
Oct 5, 2020 |
Intermountain Healthcare Researchers Develop New Diagnostic Tool to Identify & Treat Patients with COVID-19 at Risk of Severe Illness, Death Due to Inflammatory Disorder
Oct 1, 2020 |
GVN’s Top Virus Experts Meet Together To Identify Most Promising Advances To Battle COVID-19 & Strategies To Prepare For Future Pandemics
Sept 30, 2020 |
The post Insights+: COVID-19 Healthcare News Monthly Updates – October 2020 first appeared on PharmaShots.